Suchergebnisse - "Fang, Chenglong"

PubPharm (16)

1

Serum IL-6 level trajectory for predicting the effectiveness and safety of tocilizumab in the treatment of refractory Takayasu arteritis

enthalten in: European journal of internal medicine | 2024

von Sun, X. | Fang, C. | Jin, S. | +4

2

Baricitinib for refractory Takayasu arteritis : a prospective cohort study in a tertiary referral centre

enthalten in: RMD open | 2024

von Zhou, Z. | Fang, C. | Wang, L. | +6

3

Correction for : Has-miR-300-GADD45B promotes melanoma growth via cell cycle

enthalten in: Aging | 2024

von Chen, L. | Fang, C. | Yuan, X. | +4

ErratumFor: Aging (Albany NY). 2023 Dec 7;15(23):13920-13943. - PMID 38070141

4

Has-miR-300-GADD45B promotes melanoma growth via cell cycle

enthalten in: Aging | 2023

von Chen, L. | Fang, C. | Yuan, X. | +4

ErratumIn: Aging (Albany NY). 2024 Jan 14;16(1):983. - PMID 38219232

5

East-Asian lupus nephritis in the Hopkins Lupus Cohort

enthalten in: Rheumatology and immunology research | 2023

von Petri, M. | Fang, C. | Goldman, D.

6

East-Asian lupus nephritis in the Hopkins Lupus Cohort

enthalten in: Rheumatology and immunology research | 2023

von Petri, M. | Fang, C. | Goldman, D.

7

Deciphering and advancing CAR T-cell therapy with single-cell sequencing technologies

enthalten in: Molecular cancer | 2023

von Huang, S. | Wang, X. | Wang, Y. | +9

8

Deciphering and advancing CAR T-cell therapy with single-cell sequencing technologies

enthalten in: Molecular cancer | 2023

von Huang, S. | Wang, X. | Wang, Y. | +9

9

Donor-derived and off-the-shelf allogeneic anti-CD19 CAR T-cell therapy for R/R ALL and NHL : A systematic review and meta-analysis

enthalten in: Critical reviews in oncology/hematology | 2022

von Chen, S. | Zhang, Y. | Fang, C. | +5

10

4cRNA NEAT1 Sponge Adsorption of miR-378 Modulates Activity of Lipopolysaccharide-treated Articular Chondrocytes and Influences the Pathological Development of Osteoarthritis

enthalten in: Alternative therapies in health and medicine | 2022

von Wang, X. | Hu, Y. | Fang, C. | +1